HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5- (5- ((3- (4- bromophenyl)- 2- imino- 4- oxothiazolidin- 5- ylidene)methyl)furan- 2- yl)isoindoline- 1,3- dione

activates death receptor 5 (DR5); structure in first source

Also Known As:

bioymifi

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoindoles: 18
      - Phthalimides: 12
        5-(5-((3-(4-bromophenyl)-2-imino-4-oxothiazolidin-5-ylidene)methyl)furan-2-yl)isoindoline-1,3-dione: 2

Experts

1.	Alfhili, Mohammad A: 1 article (10/2021)
2.	Aljaser, Feda S: 1 article (10/2021)
3.	Alsughayyir, Jawaher: 1 article (10/2021)
4.	Basudan, Ahmed M: 1 article (10/2021)
5.	Dera, Ayed: 1 article (10/2021)

Related Diseases

1.	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/01/2022 - "The anticancer activity of the Bioymifi, which can activate apoptosis by inducing DR-5 clustering and aggregation against the human cervical cancer cell line, was investigated in the current study. " 07/01/2022 - "Bioymifi has significantly anticancer actions in Human cervix cancer in vitro and can be combined with standard treatment." 07/01/2022 - "Death receptor-dependent apoptosis and cell cycle delay induced by bioymifi in human cervical cancer cells."
2.	Anemia 10/11/2021 - "Since anemia of chemotherapy is common, our goal is to investigate the hemolytic and eryptotic properties of novel DR5 agonist bioymifi (BMF) and identify the underlying molecular mechanisms. "

Related Drugs and Biologics

1.	Death Domain Receptors

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)